If you’re like most, you probably use Outlook with its standard inbox view. You know, the main list of individual email threads along with the navigation panel on the side and maybe the email preview ...

Amicus Therapeutics FOLD reported third-quarter 2024 adjusted earnings of 10 cents per share, beating the Zacks Consensus Estimate of 8 cents. The company had incurred a loss of 1 cent per share in ...

Shares of Amicus Therapeutics, Inc. FOLD have declined almost 8.5% since its earnings release on Thursday Aug 8. However, the stock has rallied 13% so far this year versus the industry’s decrease of 0 ...

TD Cowen analyst Ritu Baral maintained a Buy rating on Amicus (FOLD – Research Report) yesterday and set a price target of $20.00. Ritu Baral has given her Buy rating due to a combination of factors ...

Crowley to Step Down from Amicus Board of Directors in March 2024 and Become Amicus Chairman Emeritus Michael Raab, Current Lead Independent Director, to Become Chairman of Amicus Board of Directors ...